FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040986050> ?p ?o ?g. }

• W3040986050 abstract "Parkinson's disease (PD) is a common neurodegenerative disease characterized by motor and cognitive deficits, the result of dopamine (DA)-depletion within the basal ganglia. Currently, DA replacement therapy in the form of Sinemet (L-DOPA plus Carbidopa) provides symptomatic motor benefits and remains the gold standard for treatment. Several pharmacological approaches can enhance DA neurotransmission including the administration of DA receptor agonists, the inhibition of DA metabolism, and enhancing pre-synaptic DA release. DA neurotransmission is regulated by several receptor subtypes including signaling through the purinergic system. P2 × 4 receptors (P2 × 4Rs) are a class of cation-permeable ligand-gated ion channels activated by the synaptic release of extracellular adenosine 5'-triphosphate (ATP). P2 × 4Rs are expressed throughout the central nervous system including the dopaminergic circuitry of the substantia nigra, basal ganglia, and related reward networks. Previous studies have demonstrated that P2 × 4Rs can modulate several DA-dependent characteristics including motor, cognitive, and reward behaviors. Ivermectin (IVM) and moxidectin (MOX) are two macrocyclic lactones that can potentiate P2 × 4Rs. In this study, we sought to investigate the role of P2 × 4Rs in mediating DA neurotransmission by exploring their impact on DA-dependent behavior, specifically rotation frequency in the unilateral 6-hydroxydopamine-lesioned mouse model of DA-depletion. While we did not observe any differences in the degree of lesioning based on immunostaining for tyrosine hydroxylase between sexes, male mice displayed a greater number of rotations with L-DOPA compared to female mice. In contrast, we observed that IVM plus L-DOPA increased the number of rotations (per 10 min) in female, but not male mice. These findings highlight the potential role of pharmacologically targeting the purinergic receptor system in modulating DA neurotransmission as well as the importance of sex differences impacting outcome measures." @default.
• W3040986050 created "2020-07-16" @default.
• W3040986050 creator A5016150271 @default.
• W3040986050 creator A5016253604 @default.
• W3040986050 creator A5021755526 @default.
• W3040986050 creator A5043188472 @default.
• W3040986050 date "2020-09-01" @default.
• W3040986050 modified "2023-09-27" @default.
• W3040986050 title "The macrocyclic lactones ivermectin and moxidectin show differential effects on rotational behavior in the 6-hydroxydopamine mouse model of Parkinson’s disease" @default.
• W3040986050 cites W1490568823 @default.
• W3040986050 cites W1529221656 @default.
• W3040986050 cites W1969394012 @default.
• W3040986050 cites W1975633296 @default.
• W3040986050 cites W1975690611 @default.
• W3040986050 cites W1982666490 @default.
• W3040986050 cites W1984833840 @default.
• W3040986050 cites W1985091985 @default.
• W3040986050 cites W1991588960 @default.
• W3040986050 cites W1992666033 @default.
• W3040986050 cites W1995494541 @default.
• W3040986050 cites W2002287054 @default.
• W3040986050 cites W2011005824 @default.
• W3040986050 cites W2027274005 @default.
• W3040986050 cites W2034788081 @default.
• W3040986050 cites W2039279856 @default.
• W3040986050 cites W2044234384 @default.
• W3040986050 cites W2045616163 @default.
• W3040986050 cites W2057210658 @default.
• W3040986050 cites W2057621975 @default.
• W3040986050 cites W2058333601 @default.
• W3040986050 cites W2062679693 @default.
• W3040986050 cites W2073378702 @default.
• W3040986050 cites W2075546748 @default.
• W3040986050 cites W2077834394 @default.
• W3040986050 cites W2086483799 @default.
• W3040986050 cites W2088327714 @default.
• W3040986050 cites W2099540110 @default.
• W3040986050 cites W2103624092 @default.
• W3040986050 cites W2104181837 @default.
• W3040986050 cites W2119835056 @default.
• W3040986050 cites W2129479963 @default.
• W3040986050 cites W2140038023 @default.
• W3040986050 cites W2149232781 @default.
• W3040986050 cites W2161776461 @default.
• W3040986050 cites W2170141518 @default.
• W3040986050 cites W2313798176 @default.
• W3040986050 cites W2402371805 @default.
• W3040986050 cites W2474368981 @default.
• W3040986050 cites W2508001580 @default.
• W3040986050 cites W2520000421 @default.
• W3040986050 cites W2552558587 @default.
• W3040986050 cites W2589517828 @default.
• W3040986050 cites W2610315419 @default.
• W3040986050 cites W2621950860 @default.
• W3040986050 cites W2760322389 @default.
• W3040986050 cites W2791102635 @default.
• W3040986050 cites W2792396898 @default.
• W3040986050 cites W2931010251 @default.
• W3040986050 cites W2946028032 @default.
• W3040986050 cites W2953791151 @default.
• W3040986050 cites W2965914746 @default.
• W3040986050 cites W3009361788 @default.
• W3040986050 cites W3029354427 @default.
• W3040986050 cites W4211258574 @default.
• W3040986050 cites W4237397855 @default.
• W3040986050 doi "https://doi.org/10.1016/j.bbr.2020.112804" @default.
• W3040986050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32668263" @default.
• W3040986050 hasPublicationYear "2020" @default.
• W3040986050 type Work @default.
• W3040986050 sameAs 3040986050 @default.
• W3040986050 citedByCount "0" @default.
• W3040986050 crossrefType "journal-article" @default.
• W3040986050 hasAuthorship W3040986050A5016150271 @default.
• W3040986050 hasAuthorship W3040986050A5016253604 @default.
• W3040986050 hasAuthorship W3040986050A5021755526 @default.
• W3040986050 hasAuthorship W3040986050A5043188472 @default.
• W3040986050 hasConcept C126322002 @default.
• W3040986050 hasConcept C134018914 @default.
• W3040986050 hasConcept C137183658 @default.
• W3040986050 hasConcept C15744967 @default.
• W3040986050 hasConcept C159167319 @default.
• W3040986050 hasConcept C169760540 @default.
• W3040986050 hasConcept C170493617 @default.
• W3040986050 hasConcept C185592680 @default.
• W3040986050 hasConcept C200170125 @default.
• W3040986050 hasConcept C2778187257 @default.
• W3040986050 hasConcept C2780062018 @default.
• W3040986050 hasConcept C2780938664 @default.
• W3040986050 hasConcept C513476851 @default.
• W3040986050 hasConcept C529278444 @default.
• W3040986050 hasConcept C71924100 @default.
• W3040986050 hasConcept C98274493 @default.
• W3040986050 hasConceptScore W3040986050C126322002 @default.
• W3040986050 hasConceptScore W3040986050C134018914 @default.
• W3040986050 hasConceptScore W3040986050C137183658 @default.
• W3040986050 hasConceptScore W3040986050C15744967 @default.
• W3040986050 hasConceptScore W3040986050C159167319 @default.
• W3040986050 hasConceptScore W3040986050C169760540 @default.
• W3040986050 hasConceptScore W3040986050C170493617 @default.
• W3040986050 hasConceptScore W3040986050C185592680 @default.

• next